In the literature there are several reports dealing with the possibility of a desensitising treatment in food allergy, but there are very few studies concerning the immunological mechanisms of oral desensitisation. We studied the immunological modifications in four children who underwent oral desensitisation with cow milk. Four children with cow milk allergy underwent oral desensitisation according to a standardized protocol. Total IgE, eosinophilic cationic protein in serum, and specific IgE and IgG 4 to a-lactalbumin, to f3-lactoglobulin and to casein were determined at the beginning of the treatment and after 6, 12 and 18 months in the 4 children treated. All the 4 treated patients successfully completed the treatment. Specific IgE to casein showed a significant reduction (p<O.OI), while specific IgG 4 to a-lactalbumin (p<O.02), to 13lactoglobulin (p<O.OI) and to casein (p<O.OI) showed a significant increase. Total IgE, eosinophilic cationic protein, and specific IgE to a-lactalbumin and to f3-lactoglobulin did not show any significant modification. Control patients did not show any immunological modification and still had a positive double-blind, placebo-controlled food challenge.
The therapy for food allergies is a problem which is still to be resolved. The first therapeutic approach to patients with food allergy is the elimination from the diet of the food the patient is allergic to. This is not always possible since the responsible food may be an essential constituent of the diet (for example egg or milk) or it could be found in other foods as hidden allergens (milk proteins can be found in ice-cream, chocolate, canned meat, ham and sausages) (1). Moreover, the elimination from the diet of foods which are fundamental for growth, such as milk or eggs, may cause nutritional imbalances and therefore growth problems in children.
A spontaneous desensitisation may occur in 19-44% of patients who follow an elimination diet, but this process generally takes years (2) (3) (4) (5) .
Other Authors found that 87% of infants loose their milk hypersensitivity only in the first 3 years of life (6) . So, when it is not possible to avoid food exposure in the environment (for example cooks or milk workers), or it is not possible to follow an adequate diet regimen for the patient, a specific desensitising treatment should be taken into consideration.
Subcutaneous desensitisation treatments have been carried out in the past, but with poor results and many side-effects (7-11), even if recent interesting results have been reported regarding rush immunotherapy for peanut allergy (12) (13) . Despite some negative opinions (9, 11, (14) (15) (16) , oral desensitisation has been carried out successfully by several authors (17) (18) (19) (20) (21) (22) (23) .
In this work we report the results and the immunological modifications we obtained in 4 children with cow milk allergy who underwent oral specific desensitisation with milk according to standard protocols (19, modified) .
MATERIALS AND METHODS
Four children, two males and two females, aged from 5 to 15 years, were investigated and they all underwent an oral desensitizing treatment with milk at the Allergology Department of the "Policlinico Gemelli" of Rome. Four other children (two males and two females aged from 5 to 13 years) with milk allergy, refused to undergo any treatment, but just followed a strict elimination diet; so these patients were chosen as a control group. An informed written consent from the children's parents and a favourable opinion from the local Ethics Committee were obtained before starting the study.
The characteristics of the treated group were as follows:
-patient I was a 13-year-old female who presented bronchial asthma and urticaria when drinking milk;
-patient 2 was a 6-year-old male who presented vomiting and bronchial asthma after the ingestion or inhalation of milk;
-patient 3 was a 5-year-old male and patient 4 was a 15-year-old female, who both presented urticaria after milk ingestion.
The characteristics of the control group were as follows:
-patient 5 was a 13-year-old female and patient 6 was a 5-year-old male who both presented urticaria when drinking milk; -patient 7 was a l l-year-old female and patient 8 was a IO-year-old male who both presented asthma and vomiting after milk ingestion.
The diagnosis of milk allergy was made through the medical history and a complete allergological evaluation: 1) skin prick tests with a-lactalbumin (a-LA), ,B-Iactoglobulin (,B-LG), casein (CS) and crude milk; -a wheal reaction at least 3 mm larger than those induced by negative control (saline) was considered positive; 2) detection in serum of total and specific IgE (UniCAP, Pharmacia, Uppsala, Sweden) to a-LA, ,B-
LG and CS, and of eosinophilic cationic protein (ECP) (UniCAP, Pharmacia); 3) the double-blind, placebocontrolled, food challenge (DBPCFC). Specific IgG 4 to the same allergens were also measured (CAP FEIA, Pharmacia).
The DBPCFC was conducted administering the allergen (in this case milk) diluted in vanillin. Vanillin alone ,was used as placebo.
The DBPCFC was performed after two days, administering the placebo or milk, with a three-day interval, at increasing doses every half-an-hour: for milk the doses were of 0.0 1,0.1,0.5, 1,5, 10 and 30 ml. The test was interrupted if any adverse reaction occurred.
After the DBPCFC the patients were followed for 8 hours and they had to record any reaction in a diary.
The DBPCFC was considered as positive when I or more of the following symptoms appeared:
-urticaria/angio-oedema or erythema with pruritus; -rhinitis, rhinorrhea or nasal obstruction; -bronchial asthma; -vomiting and/or diarrhoea and abdominal pain; -general malaise, collapse, loss of consciousness. An oral desensitising treatment with milk was then performed according to a standardized protocol (Tab. I); at first we administered increasing doses of milk diluted in water and then the pure milk (19, modified) . The doses in the treatment protocol were given at home and the patients were followed every 15 days in a day-hospital regimen. That has to be considered a theoretical protocol of desensitisation, since if any adverse reaction occurs, the doses must be increased slowly. This fact explains the discrepancy of the length of the treatment in the various patients.
Both groups were followed for 18 months. Total and specific IgE, specific IgG 4 and ECP in serum were then detected at 6, 12 and 18 months after the beginning of the treatment; skin prick tests were repeated after I year.
The statistical analysis of the obtained data was performed by means of two-way variance analysis.
RESULTS
The DBPCFC was positive in all patients: -patient 1 presented bronchial asthma and urticaria, which needed therapy with methylprednisolone and clorphenamine after drinking 30 ml of milk;
-patient 2 presented abdominal pain, bronchial asthma and vomiting and needed therapy with methylprednisolone and cetirizine afterthe ingestion of 30 ml of milk;
-_patient 3 presented urticaria and needed therapy with cetirizine after drinking 0.1 ml of milk;
Starting dilution: 10 drops of milk in 10 ml of water Tab. I. Oral specific desensitization in patients allergic to milk (19, modified 40 ml x 3 50 ml x 2 65 ml x 2 80 ml x 2 100 ml 120 ml -patient 4 presented nausea and angioedema of the lips after drinking 3 ml of milk and needed therapy with cetirizine; -patient 5 and patient 6 both presented urticaria after the ingestion of 10 and 1 ml of milk, respectively; -patient 7 and patient 8 both presented bronchial asthma and vomiting after the ingestion of 5 ml of milk.
All the 4 patients completed the desensitizing treatment in 4 to 8 months, because sometimes some mild side-effects occurred and so we had to increase the doses slowly: patient 1 presented angioedema ofthe lips and rhinitis which required the use of cetirizine and sodium cromolyn while patient 2 presented urticaria and worsening of atopic dermatitis which needed the use of cetirizine. At the end of the treatment all patients could tolerate 120 ml of milk with no side-effects and could eat dairy products and foods containing milk (sweets, milk chocolate, fresh and fermented cheeses).
None of the patients needed corticosteroids or hospitalisation during the treatment.
During the oral desensitising treatment, we found in the 4 treated children, a significant reduction of specific IgE to CS (F=7.85; d.f.=3-9; p<O.Ol), accompanied by a contemporary significant increase of specific IgG 4 to a-LA (F=5.24; d.f.=3-9; p<0.02), to I3-LG (F=9.78; d.f.=3-9; p<O.OI) and to CS (F=7.27; d.f.= 3-9; p<O.OI). Total IgE, ECP and specific IgE to a-LA and to I3-LG did not show significant variations (Tab. II and III). Skin prick tests, strongly positive at the beginning, turned completely negative or showed a great decrease after 1 year.
As regards the patients who just followed the elimination diet, we did not find any significant immunological modification (specific IgE and IgG 4 did not vary).
Moreover, the DBPCFC was still positive after 18 months of elimination diet, while the treated patients could drink 120 ml of milk a day.
DISCUSSION

Maintenance dose: 120 ml of milk (about 1 glass) at least 2-3 times a week
The problem of desensitisation in food allergy is still a matter of debate.
Subcutaneous desensitisation for peanut allergy, has bee!l performed by some authors (12-13 with very severe side-effects (some patients needed epinephrine); moreover no immunological modifications were observed. At the end of the treatment, a reduction of skin prick test reactivity and of symptom score after DBPCFC were observed. The possibility of obtaining an oral desensitisation in patients with food allergy, is considered with interest but also with scepticism; so oral desensitisation for food allergy has always been considered an unproved technique.
In fact, the exact mechanisms of the induction of oral tolerance are still not well known, even if some hypothesis (24) (25) have been made: a) antigen-driven suppression; b) clonal anergy; c) clonal deletion; d) bystander suppression.
In allergic patients (atopic) there is an imbalance between the T CD4+ lymphocyte subsets, with an increase of Th2, that produce mainly interleukin-4 (IL-4), and a decrease of Thl, that produce mainly interferon-v (IFN-y); IL-4 promote IgE synthesis, while IFN-y inhibits it.
In atopic patients, exposure to the allergen causes a Th2 response, with production of IL-3, IL-4, IL-5, IL-6 and IL-13 that determine a hyperproduction of IgE and, on the other hand, eosinophil activation; the activated eosinophils release several inflammatory proteins such as ECP, MBP, EPX, etc.
It has been hypothesised that in respiratory allergy, the hyposensitising treatment, could induce a switch from a prevalent Th2 response to a prevalent Thl response, with a consequent increase ofIFN-y.
Recently, the World Health Organisation stated that the sublingual-swallow therapy has demonstrated evidence of clinical efficacy for the treatment of respiratory allergies (26) .
On the other hand, in a murine model (27) , it has been observed that oral administration of chitosan-DNA nanoparticles, that code for the allergen Ara h2 of peanut, induces the production of secretory IgA and serum IgG2a directed against that allergen; so the animal was protected against new episodes of anaphylaxis caused by peanuts.
Moreover, new techniques for the treatment of food allergy are under investigation: peptide immunotherapy, mutated protein immunotherapy, allergen DNA immunization, vaccination with immunostimolatory DNA sequences and antiimmunoglobulin E (anti-IgE) therapy (28) .
During the oral desensitising treatment, we found a significant reduction of specific IgE to CS, accompanied by an increase of specific IgG 4 to a-LA, to {3-LG and to casein in the 4 children we treated. This confirms another study of our (21) in which, in a patient desensitised with milk, we observed a reduction of the production of IL-4 and an increase of the production of IFN-y by T lymphocytes, both spontaneously, and when induced by the allergen or by mitogen.
These data lead us to hypothesise that oral desensitisation with food allergen occurs with the same mechanisms and is as effective as desensitisation for respiratory allergy.
Spontaneous desensitisation is very unlikely, since this phenomenon generally takes years (2) (3) (4) (5) and the avoidance of the allergenic food is necessary. In our case, all patients were desensitised in less time (about 4-8 months) while eating the food they were allergic to, every day at increasing doses.
Moreover, the persistence of the positivity of the DBPCFC in all control subjects rules out the possibility that our results could be due to a spontaneous desensitisation.
So, even if further studies are needed to explain the pathophysiology of oral desensitisation, this treatment should be taken into consideration for the therapy of food allergies, especially for children, in which elimination diets may cause nutritional and growth problems.
